Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

HSA Approval

TALZENNA CAPSULE 0.5MG

Approval Number

SIN17240P

Drug Name

TALZENNA CAPSULE 0.5MG

Product Name

TALZENNA CAPSULE 0.5MG

Approval Date

May 21, 2025

Registrant

PFIZER PRIVATE LIMITED

Regulatory Information

Registrant

PFIZER PRIVATE LIMITED

Drug Type

Therapeutic

Forensic Classification

Prescription Only

Formulation Information

Dosage Form

CAPSULE

Route of Administration

ORAL

Medical Information

ATC Code

L01XK04

Manufacturer Information

Pharmaceutical Manufacturer

PFIZER PRIVATE LIMITED

Manufacturers

Excella GmbH & Co. KG

Active Ingredients

Ingredient Name

Talazoparib tosylate eqv Talazoparib

Strength

0.5 mg

Drug MonographTalazoparib

Documents

Package Inserts

Talzenna Capsule PI.pdf

Approved: May 21, 2025

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy